2003
DOI: 10.1016/s1471-4906(02)00013-3
|View full text |Cite
|
Sign up to set email alerts
|

IL-6: a regulator of the transition from neutrophil to monocyte recruitment during inflammation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

27
479
1
20

Year Published

2004
2004
2023
2023

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 702 publications
(527 citation statements)
references
References 34 publications
27
479
1
20
Order By: Relevance
“…In addition to PGE 2 , inflammation mediators can induce the release of other inflammatory cytokines such as IL‐6. Several previous studies demonstrated that IL‐6 plays an important role in ocular inflammation 31, 32, 33, 34. In this study, we found that production of IL‐6 increased 4.6 and 6.3 times in tears and aqueous humor, respectively, after ocular inflammation was induced.…”
Section: Resultssupporting
confidence: 62%
“…In addition to PGE 2 , inflammation mediators can induce the release of other inflammatory cytokines such as IL‐6. Several previous studies demonstrated that IL‐6 plays an important role in ocular inflammation 31, 32, 33, 34. In this study, we found that production of IL‐6 increased 4.6 and 6.3 times in tears and aqueous humor, respectively, after ocular inflammation was induced.…”
Section: Resultssupporting
confidence: 62%
“…Our work also demonstrates that aloe-emodin markedly suppresses the LPS-stimulated transcription and production of IL-1β and IL-6. IL-1β is an early major pro-inflammatory cytokine mediating the inflammatory response at both the local and systemic levels (Dinarello, 2000), and IL-6 plays an important role in a variety of inflammatory conditions, especially in acute-phase responses (Heinrich et al, 1990;Kaplanski et al, 2003). Collectively our data indicate that the anti-inflammatory effect of aloe-emodin is due, at least in part, to its inhibitory effects on the expression of pro-inflammatory mediators.…”
Section: Discussionmentioning
confidence: 69%
“…IL-6 is a strong activator of acute phase response contributing both systemic and local inflammatory response. It activates vascular endothelial cells leading to a release of chemokines e.g., IL-8, and monocyte chemoattractant protein-1, which facilitates leukocyte recruitment to inflammatory sites (Kaplanski et al, 2003). Elevated serum IL-6 in cancer patients or in tumor biopsy indicated that this cytokine plays role in cancer development (Chung et al, 2003;Kai et al, 2005).…”
Section: Discussionmentioning
confidence: 99%